122 related articles for article (PubMed ID: 36933308)
41. PRR11 Is a Prognostic Marker and Potential Oncogene in Patients with Gastric Cancer.
Song Z; Liu W; Xiao Y; Zhang M; Luo Y; Yuan W; Xu Y; Yu G; Hu Y
PLoS One; 2015; 10(8):e0128943. PubMed ID: 26252227
[TBL] [Abstract][Full Text] [Related]
42. NDRG4 hypermethylation is a potential biomarker for diagnosis and prognosis of gastric cancer in Chinese population.
Chen X; Yang Y; Liu J; Li B; Xu Y; Li C; Xu Q; Liu G; Chen Y; Ying J; Duan S
Oncotarget; 2017 Jan; 8(5):8105-8119. PubMed ID: 28042954
[TBL] [Abstract][Full Text] [Related]
43. Up-regulation of brain-expressed X-linked 2 is critical for hepatitis B virus X protein-induced hepatocellular carcinoma development.
Huang F; Cai P; Wang Y; Zhou X; Chen H; Liao W; Mao Y; Zha X; Zhang H; Hu Z
Oncotarget; 2017 Sep; 8(39):65789-65799. PubMed ID: 29029472
[TBL] [Abstract][Full Text] [Related]
44. Long non-coding RNA SNHG3, induced by IL-6/STAT3 transactivation, promotes stem cell-like properties of gastric cancer cells by regulating the miR-3619-5p/ARL2 axis.
Sun B; Han Y; Cai H; Huang H; Xuan Y
Cell Oncol (Dordr); 2021 Feb; 44(1):179-192. PubMed ID: 32930970
[TBL] [Abstract][Full Text] [Related]
45. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
Ma X; Wang B; Wang X; Luo Y; Fan W
PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
[TBL] [Abstract][Full Text] [Related]
46. Leucine-rich repeat neuronal protein-1 suppresses apoptosis of gastric cancer cells through regulation of Fas/FasL.
Liu B; Zhang Y; Fan Y; Wang S; Li Z; Deng M; Li C; Wang J; Ma R; Wang X; Wang Y; Xu L; Hou K; Che X; Liu Y; Qu X
Cancer Sci; 2019 Jul; 110(7):2145-2155. PubMed ID: 31087525
[TBL] [Abstract][Full Text] [Related]
47. RNA binding protein Lin28B confers gastric cancer cells stemness via directly binding to NRP-1.
Wang X; Hu H; Liu H
Biomed Pharmacother; 2018 Aug; 104():383-389. PubMed ID: 29787985
[TBL] [Abstract][Full Text] [Related]
48. Gene targeting study reveals unexpected expression of brain-expressed X-linked 2 in endocrine and tissue stem/progenitor cells in mice.
Ito K; Yamazaki S; Yamamoto R; Tajima Y; Yanagida A; Kobayashi T; Kato-Itoh M; Kakuta S; Iwakura Y; Nakauchi H; Kamiya A
J Biol Chem; 2014 Oct; 289(43):29892-911. PubMed ID: 25143383
[TBL] [Abstract][Full Text] [Related]
49. BRD4 promotes the stemness of gastric cancer cells via attenuating miR-216a-3p-mediated inhibition of Wnt/β-catenin signaling.
Song H; Shi L; Xu Y; Xu T; Fan R; Cao M; Xu W; Song J
Eur J Pharmacol; 2019 Jun; 852():189-197. PubMed ID: 30876979
[TBL] [Abstract][Full Text] [Related]
50. Upregulation of KPNβ1 in gastric cancer cell promotes tumor cell proliferation and predicts poor prognosis.
Zhu J; Wang Y; Huang H; Yang Q; Cai J; Wang Q; Gu X; Xu P; Zhang S; Li M; Ding H; Yang L
Tumour Biol; 2016 Jan; 37(1):661-72. PubMed ID: 26242264
[TBL] [Abstract][Full Text] [Related]
51. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy.
Chen JF; Wu P; Xia R; Yang J; Huo XY; Gu DY; Tang CJ; De W; Yang F
Mol Cancer; 2018 Jan; 17(1):6. PubMed ID: 29329543
[TBL] [Abstract][Full Text] [Related]
52. Significance of aquaporins' expression in the prognosis of gastric cancer.
Thapa S; Chetry M; Huang K; Peng Y; Wang J; Wang J; Zhou Y; Shen Y; Xue Y; Ji K
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29678898
[TBL] [Abstract][Full Text] [Related]
53. RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer.
Cheng Y; Yang B; Xi Y; Chen X
Tumour Biol; 2016 Nov; 37(11):14969-14978. PubMed ID: 27651161
[TBL] [Abstract][Full Text] [Related]
54. USP22 maintains gastric cancer stem cell stemness and promotes gastric cancer progression by stabilizing BMI1 protein.
Ma Y; Fu HL; Wang Z; Huang H; Ni J; Song J; Xia Y; Jin WL; Cui DX
Oncotarget; 2017 May; 8(20):33329-33342. PubMed ID: 28415621
[TBL] [Abstract][Full Text] [Related]
55. Over-expression of oncigenic pesudogene DUXAP10 promotes cell proliferation and invasion by regulating LATS1 and β-catenin in gastric cancer.
Xu Y; Yu X; Wei C; Nie F; Huang M; Sun M
J Exp Clin Cancer Res; 2018 Jan; 37(1):13. PubMed ID: 29374493
[TBL] [Abstract][Full Text] [Related]
56. LAMC1 is related to the poor prognosis of patients with gastric cancer and facilitates cancer cell malignancies.
Han ZR; Jiang XL; Fan WC
Neoplasma; 2021 Jul; 68(4):711-718. PubMed ID: 33884884
[TBL] [Abstract][Full Text] [Related]
57. MAFG-AS1 is a novel clinical biomarker for clinical progression and unfavorable prognosis in gastric cancer.
Li C; Wu R; Xing Y
Cell Cycle; 2020 Mar; 19(5):601-609. PubMed ID: 32079456
[TBL] [Abstract][Full Text] [Related]
58. Recent advances in molecular diagnosis and therapy of gastric cancer.
Chen J; Röcken C; Malfertheiner P; Ebert MP
Dig Dis; 2004; 22(4):380-5. PubMed ID: 15812163
[TBL] [Abstract][Full Text] [Related]
59. BCAR4 increase cisplatin resistance and predicted poor survival in gastric cancer patients.
Wang L; Chunyan Q; Zhou Y; He Q; Ma Y; Ga Y; Wang X
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4064-4070. PubMed ID: 29028095
[TBL] [Abstract][Full Text] [Related]
60. Reduced USP33 expression in gastric cancer decreases inhibitory effects of Slit2-Robo1 signalling on cell migration and EMT.
Xia Y; Wang L; Xu Z; Kong R; Wang F; Yin K; Xu J; Li B; He Z; Wang L; Xu H; Zhang D; Yang L; Wu JY; Xu Z
Cell Prolif; 2019 May; 52(3):e12606. PubMed ID: 30896071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
